| ČULEN, Martin, Zdeňka HERUDKOVÁ, Ivana JEŽÍŠKOVÁ, Adam FOLTA, Nikola TOM, Ondřej VENGLÁŘ, Dana DVOŘÁKOVÁ, Jiří MAYER and Zdeněk RÁČIL. Persistence of mutations during remission in 114 AML patients. In Blood. 2018. ISSN 0006-4971. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{1492319,
author = {Čulen, Martin and Herudková, Zdeňka and Ježíšková, Ivana and Folta, Adam and Tom, Nikola and Venglář, Ondřej and Dvořáková, Dana and Mayer, Jiří and Ráčil, Zdeněk},
booktitle = {Blood},
keywords = {AML - mutations - remission - NGS},
language = {eng},
title = {Persistence of mutations during remission in 114 AML patients.},
year = {2018}
}
TY - CONF
ID - 1492319
AU - Čulen, Martin - Herudková, Zdeňka - Ježíšková, Ivana - Folta, Adam - Tom, Nikola - Venglář, Ondřej - Dvořáková, Dana - Mayer, Jiří - Ráčil, Zdeněk
PY - 2018
TI - Persistence of mutations during remission in 114 AML patients.
KW - AML - mutations - remission - NGS
N2 - The current prognostic stratification of acute myeloid leukemia (AML) patients recognizes several recurrently mutated genes in AML as prognostic markers at the time of diagnosis. However, previous studies indicate that additional prognostic information can be further obtained by detection of pre-leukemic mutations that persist in clinical remission and represent clonal hematopoiesis.
ER -
ČULEN, Martin, Zdeňka HERUDKOVÁ, Ivana JEŽÍŠKOVÁ, Adam FOLTA, Nikola TOM, Ondřej VENGLÁŘ, Dana DVOŘÁKOVÁ, Jiří MAYER and Zdeněk RÁČIL. Persistence of mutations during remission in 114 AML patients. In \textit{Blood}. 2018. ISSN~0006-4971.
|
